Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-17-061846
Filing Date
2017-10-11
Accepted
2017-10-11 20:34:56
Documents
1
Period of Report
2017-10-09

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3922
  Complete submission text file 0001104659-17-061846.txt   5291
Mailing Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494 (781) 292-4200
Verastem, Inc. (Issuer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERASTEM, INC.; 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494
Business Address
Le NgocDiep T. MD, PhD (Reporting) CIK: 0001719331 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35403 | Film No.: 171133614